Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Use of Proteins Identified through a Functional Genomic Screen To Develop a Protein Subunit Vaccine That Provides Significant Protection against Virulent Streptococcus suis in Pigs.

Brockmeier SL, Loving CL, Nicholson TL, Wang J, Peters SE, Weinert L, Chaudhuri R, Seilly DJ, Langford PR, Rycroft A, Wren BW, Maskell DJ, Tucker AW.

Infect Immun. 2018 Feb 20;86(3). pii: e00559-17. doi: 10.1128/IAI.00559-17. Print 2018 Mar.

2.

Vaccination with Streptococcus suis serotype 2 recombinant 6PGD protein provides protection against S. suis infection in swine.

Tan C, Liu M, Liu J, Yuan F, Fu S, Liu Y, Jin M, Bei W, Chen H.

FEMS Microbiol Lett. 2009 Jul;296(1):78-83. doi: 10.1111/j.1574-6968.2009.01617.x. Epub 2009 May 5.

3.

Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.

Kock C, Beineke A, Seitz M, Ganter M, Waldmann KH, Valentin-Weigand P, Baums CG.

Vet Immunol Immunopathol. 2009 Dec 15;132(2-4):135-45. doi: 10.1016/j.vetimm.2009.05.009. Epub 2009 May 18.

PMID:
19505730
4.

Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9.

Jiang X, Yang Y, Zhu L, Gu Y, Shen H, Shan Y, Li X, Wu J, Fang W.

Vaccine. 2016 Dec 12;34(51):6529-6538. doi: 10.1016/j.vaccine.2016.05.003. Epub 2016 Jun 24.

PMID:
27349838
5.

Characterization of the immune response and evaluation of the protective capacity of rSsnA against Streptococcus suis infection in pigs.

Gómez-Gascón L, Cardoso-Toset F, Tarradas C, Gómez-Laguna J, Maldonado A, Nielsen J, Olaya-Abril A, Rodríguez-Ortega MJ, Luque I.

Comp Immunol Microbiol Infect Dis. 2016 Aug;47:52-9. doi: 10.1016/j.cimid.2016.06.001. Epub 2016 Jun 4.

PMID:
27477507
6.

Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.

Li Y, Gottschalk M, Esgleas M, Lacouture S, Dubreuil JD, Willson P, Harel J.

Clin Vaccine Immunol. 2007 Aug;14(8):937-43. Epub 2007 Jun 13.

7.

Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2.

Li J, Xia J, Tan C, Zhou Y, Wang Y, Zheng C, Chen H, Bei W.

Vaccine. 2011 Sep 2;29(38):6514-9. doi: 10.1016/j.vaccine.2011.07.010. Epub 2011 Jul 19.

PMID:
21767591
8.

Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization.

Dekker CN, Bouma A, Daemen AJ, van Leengoed LA, Jonker FH, Wagenaar JA, Stegeman JA.

Vaccine. 2012 Feb 8;30(7):1379-87. doi: 10.1016/j.vaccine.2011.12.035. Epub 2011 Dec 29.

PMID:
22210137
9.

Evaluation on a Streptococcus suis vaccine using recombinant sao-l protein manufactured by bioreactors as the antigen in pigs.

Hsueh KJ, Lee JW, Hou SM, Chen HS, Chang TC, Chu CY.

Transbound Emerg Dis. 2014 Dec;61(6):e35-43. doi: 10.1111/tbed.12067. Epub 2013 Mar 12.

PMID:
23489297
10.

Peptidyl isomerase PrsA is surface-associated on Streptococcus suis and offers cross-protection against serotype 9 strain.

Jiang X, Yang Y, Zhou J, Liu H, Liao X, Luo J, Li X, Fang W.

FEMS Microbiol Lett. 2019 Jan 1;366(2). doi: 10.1093/femsle/fnz002.

PMID:
30629173
11.

Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9.

Baums CG, Kock C, Beineke A, Bennecke K, Goethe R, Schröder C, Waldmann KH, Valentin-Weigand P.

Clin Vaccine Immunol. 2009 Feb;16(2):200-8. doi: 10.1128/CVI.00371-08. Epub 2008 Dec 24.

12.

Streptococcus suis vaccines: candidate antigens and progress.

Segura M.

Expert Rev Vaccines. 2015;14(12):1587-608. doi: 10.1586/14760584.2015.1101349. Epub 2015 Oct 15. Review.

PMID:
26468755
13.

Comparative immunosecretome analysis of prevalent Streptococcus suis serotypes.

Gómez-Gascón L, Luque I, Tarradas C, Olaya-Abril A, Astorga RJ, Huerta B, Rodríguez-Ortega MJ.

Comp Immunol Microbiol Infect Dis. 2018 Apr;57:55-61. doi: 10.1016/j.cimid.2018.06.006. Epub 2018 Jun 13.

PMID:
30017079
14.

Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy.

Büttner N, Beineke A, de Buhr N, Lilienthal S, Merkel J, Waldmann KH, Valentin-Weigand P, Baums CG.

Vet Immunol Immunopathol. 2012 May 15;146(3-4):191-200. doi: 10.1016/j.vetimm.2012.03.012. Epub 2012 Mar 30.

PMID:
22516423
15.

Potential use of an unencapsulated and aromatic amino acid-auxotrophic Streptococcus suis mutant as a live attenuated vaccine in swine.

Fittipaldi N, Harel J, D'Amours B, Lacouture S, Kobisch M, Gottschalk M.

Vaccine. 2007 May 4;25(18):3524-35. Epub 2007 Jan 30.

PMID:
17296252
16.

Understanding the virulence of Streptococcus suis: A veterinary, medical, and economic challenge.

Haas B, Grenier D.

Med Mal Infect. 2018 May;48(3):159-166. doi: 10.1016/j.medmal.2017.10.001. Epub 2017 Nov 6. Review.

PMID:
29122409
17.

Genome-wide analysis of an avirulent strain that induces protective immunity against challenge with virulent Streptococcus suis serotype 2.

Wang J, Feng Y, Wang C, Zheng F, Hassan B, Zhi L, Li W, Yao Y, He E, Jiang S, Tang J.

BMC Microbiol. 2017 Mar 14;17(1):67. doi: 10.1186/s12866-017-0971-0. Erratum in: BMC Microbiol. 2017 Jul 4;17 (1):152.

18.
19.

Evaluation of the protective efficacy of four novel identified membrane associated proteins of Streptococcus suis serotype 2.

Zhou Y, Wang Y, Deng L, Zheng C, Yuan F, Chen H, Bei W, Li J.

Vaccine. 2015 May 5;33(19):2254-2260. doi: 10.1016/j.vaccine.2015.03.038. Epub 2015 Mar 25.

PMID:
25820064
20.

Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2.

Wisselink HJ, Stockhofe-Zurwieden N, Hilgers LA, Smith HE.

Vet Microbiol. 2002 Jan 3;84(1-2):155-68.

PMID:
11731168

Supplemental Content

Support Center